Document Type : Original Article
Medical Surgical Nursing, Faculty of Nursing, Minia University, Egypt
Community Health Nursing, Faculty of Nursing, Minia University, Egypt
Psychiatric and Mental Health Nursing, Faculty of Nursing, Minia University, Egypt
Medical Surgical Nursing, Faculty of Nursing, Cairo University, Egypt
Background: One of the most significant epidemics of the century, the COVID-19 virus disease is brought on by severe respiratory syndrome and poses a threat to human health globally. Study aim: to investigate the correlation between risk of diabetes and stress and cortisone regimen among patients with COVID 19. Design: It made use of a descriptive correlational design. Setting: this study was carried out at Minia Cardiothoracic University Hospital Subjects: convenient sample of 802 hospitalized patients typical COVID-19. Data collection tools: Tool (1) structured interview questionnaire, it include (socio-demographic data, medical information, laboratory investigation record and cortisone therapy monitoring). Ordinal Scale for Clinical Improvement, Type 2 diabetes risk form and Perceived Stress Scale. Results 31.3% of COVID-19 patients have low risk for type 2 diabetes, 7.5% of sample have high risk, and 52.2% of study sample use cortisone therapy < 7 days and 47% of patients suffer from severe stress. There was a high positive significant correlation among diabetes risk assessment and duration of cortisone use and level of stress. Conclusions: The data suggest that the correlation between diabetes occurrence following COVID-19 infection and diabetes risk, stress level, duration of cortisone use, and severity of the COVID-19 infection. Recommendation All COVID-19 patients should be acquire continuous glucose monitoring or to self-monitor their blood sugar levels frequently. The goal of continued monitoring is to identify pre-diabetic patients early and reduce their risk of acquiring diabetes.